Search

everythinglearnresearchcommunity

for

Search:↓

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Sarcoptes scabiei infection causes significant health and behavior changes in wombats.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Leprosy is mainly contracted during infancy or childhood.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

The symposium concluded that environmental factors significantly contribute to skin aging.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.